The Novartis Commitment to Patients and Caregivers

On 14th February 2026, Novartis celebrated the eighth anniversary of the Novartis Commitment to Patients and Caregivers – a milestone that reflects our promise to place patients at the center of every decision we make. 

This Commitment was co-created with the patient community in 2018 to further ensure we partner with patients and caregivers to embed their lived experiences throughout the development of medicines. From early research, through to trials and post-launch, patient partner organisations have helped us make decisions that are informed by, and relevant to patients and caregivers.

Our Commitment is continuous, and we are always working to strengthen our patient partnerships, and while much remains to be done, we wanted to invite you to read about the meaningful progress made in 2025 summarized in our factsheet below. This details the progress made in four key areas, defined and achieved together with patient organizations, known as the pillars of Commitment: Respecting and understanding the patient community, conducting responsible clinical trials, expanding access to our medicines, and recognizing the importance of transparency and reporting.

Our partnership with patient organisation is instrumental in reimaging medicines together as it allows us to immerse robust patient experience data within our work to design better trials, accelerate development and access, and ensure innovations address real-world needs. 

Thank you for to all the patient organisation in Ireland for your invaluable collaboration and support 

We remain fully committed to listening and learning from you as we continue to evolve together, and we look forward to our continued partnership.